2011

Emerging Therapeutic Targets in Ovarian Cancer

Editors:

ISBN: 978-1-4419-7215-6 (Print) 978-1-4419-7216-3 (Online)

Table of contents (13 chapters)

  1. Front Matter

    Pages i-xiii

  2. No Access

    Book Chapter

    Pages 1-33

    Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs

  3. No Access

    Book Chapter

    Pages 35-50

    Discovery of Novel Targets

  4. No Access

    Book Chapter

    Pages 51-72

    Novel Anti-angiogenic Therapies in Ovarian Cancer

  5. No Access

    Book Chapter

    Pages 73-94

    Targeting the AKT Pathway in Ovarian Cancer

  6. No Access

    Book Chapter

    Pages 95-107

    Inhibition of the Src Oncogene: Therapeutic Potential in Ovarian Carcinoma

  7. No Access

    Book Chapter

    Pages 109-132

    Tumour-Specific Synthetic Lethality: Targeting BRCA Dysfunction in Ovarian Cancer

  8. No Access

    Book Chapter

    Pages 133-164

    Targeting Inflammatory Pathways in Epithelial Ovarian Cancer

  9. No Access

    Book Chapter

    Pages 165-187

    Epithelial-to-Mesenchymal Transition and Cellular Membrane Receptors in Ovarian Cancer: Moving Forward in the Era of Molecularly Targeted Therapy

  10. No Access

    Book Chapter

    Pages 189-202

    Epigenetic Therapies

  11. No Access

    Book Chapter

    Pages 203-221

    Ovarian Cancer Immunology and Immunotherapy

  12. No Access

    Book Chapter

    Pages 223-244

    Ovarian Cancer Progenitor/Stem Cells: Therapeutic Potential

  13. No Access

    Book Chapter

    Pages 245-258

    Potential for α-Folate Receptor-Targeted Treatment for Ovarian Cancer

  14. No Access

    Book Chapter

    Pages 259-278

    New Insights into Tubulin Binders

  15. Back Matter

    Pages 279-291